Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,168,525 papers from all fields of science
Search
Sign In
Create Free Account
Eescula
Known as:
Rescula
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
isopropyl unoprostone
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Effect of different dose schedules of 0.15% unoprostone isopropyl on intraocular pressure and pupil size in the glaucomatous beagle.
K. Gelatt
,
E. Mackay
,
T. Dashiell
,
Alison Biken
Journal of Ocular Pharmacology and Therapeutics
2004
Corpus ID: 26123455
The changes in intraocular pressure (IOP) and pupil size (PS) after instillations of 0.15% unoprostone isopropyl (Rescula…
Expand
2004
2004
[Effect of various anti-glaucoma eyedrops on human corneal epithelial cells].
Yumiko Aoyama
,
Masamitsu Motoki
,
M. Hashimoto
Nippon Ganka Gakkai zasshi
2004
Corpus ID: 42870716
PURPOSE To investigate the effects of antiglaucoma eyedrops and vehicles on the proliferation of human corneal epithelial cells…
Expand
2002
2002
Long-term effect of topically applied isopropyl unoprostone on microcirculation in the human ocular fundus.
Y. Makimoto
,
T. Sugiyama
,
S. Kojima
,
I. Azuma
Japanese Journal of Ophthalmology
2002
Corpus ID: 34768661
2001
2001
[Clinical evaluation of isopropyl unoprostone (Rescula), in the adjunctive treatment of primary open angle glaucoma].
T. Żarnowski
,
P. Kawa
,
J. Jurkowska-Dudzińska
,
Z. Zagórski
Klinika oczna
2001
Corpus ID: 22895057
AIM To investigate the clinical characteristics of docosanoid derivative, isopropyl unoprostone in the treatment of primary open…
Expand
2000
2000
The effect of 0.12% unoprostone isopropyl (rescula) on intraocular pressure in normotensive dogs.
Ron Ofri
,
D. Raz
,
P. Kass
,
G. Lambrou
,
C. Percicot
Journal of Veterinary Medical Science
2000
Corpus ID: 22388060
Rescula (0.12% unoprostone isopropyl) is the first docosanoid compound approved for treatment of glaucoma in humans. It is…
Expand
2000
2000
[Long-term effect of topically applied isopropyl unoprostone on microcirculation in the choroid-retina].
Y. Makimoto
,
T. Sugiyama
,
S. Kojima
,
I. Azuma
Nippon Ganka Gakkai zasshi
2000
Corpus ID: 23862837
PURPOSE To study the long-term effect of topically applied 0.12% isopropyl unoprostone (unoprostone, Rescula) on microcirculation…
Expand
2000
2000
Substituting latanoprost (Xalatan) for isopropyl unoprostone (Rescula) in monotherapy and combination therapy.
H. Tsukamoto
,
T. Yokoyama
,
K. Okada
,
M. Okada
,
H. Mochizuki
,
H. Mishima
Acta ophthalmologica
2000
Corpus ID: 38695103
Highly Cited
1998
Highly Cited
1998
A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes.
J. Serle
,
S. M. Podos
,
Yoshiaki Kitazawa
,
Rong-Fang Wang
Japanese Journal of Ophthalmology
1998
Corpus ID: 7527599
Highly Cited
1993
Highly Cited
1993
Double-masked comparative study of UF-021 and timolol ophthalmic solutions in patients with primary open-angle glaucoma or ocular hypertension.
I. Azuma
,
K. Masuda
,
Y. Kitazawa
,
M. Takase
,
H. Yamamura
Japanese Journal of Ophthalmology
1993
Corpus ID: 12679201
A double-masked comparative clinical study of UF-021 (Rescula), a unique prostaglandin-related compound, was carried out at 18…
Expand
1993
1993
[The clinical evaluation of UF-021, a new prostaglandin related compound, in low tension glaucoma patients].
C. Fujimori
,
S. Yamabayashi
,
+5 authors
R. Ueno
Nippon Ganka Gakkai zasshi
1993
Corpus ID: 38571552
We administered UF-021 isopropyl unoprostone (Rescula) ophthalmic solution, a new prostaglandin-related compound developed as an…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE